News + Filings Transactions Holdings
|
BIOTECHNOLOGY VALUE FUND L P
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Xenon Pharmaceuticals Inc.
| XENE | COM | 5,157,486 | 1,658,140 | 161,119,863 | 107,299,921 | | |
Hist
| 12/31/2021 |
Protagonist Therapeutics, Inc
| PTGX | Common | 4,891,945 | 616,980 | 167,304,519 | 81,121,225 | | |
Hist
| 12/31/2021 |
Forte Biosciences, Inc.
| TOCA | Common | 1,344,262 | 254,279 | 48,944,579 | 47,571,201 | | |
Hist
| 12/31/2020 |
ABBOTT BIOTHERAPEUTICS CORP
| FACT | COM | 3,683,521 | 1,876,900 | 59,488,864 | 43,247,341 | | |
Hist
| 09/08/2009 |
NEKTAR THERAPEUTICS
| NKTR | Common | 7,415,400 | 6,889,900 | 38,041,002 | 33,143,342 | | |
Hist
| 12/14/2011 |
Syndax Pharmaceuticals Inc
| SNDX | Common | 4,931,879 | 1,221,190 | 107,958,831 | 25,433,108 | | |
Hist
| 12/31/2021 |
Eledon Pharmaceuticals, Inc.
| NVUS | Common | 1,503,121 | 1,307,795 | 23,148,063 | 22,961,918 | | |
Hist
| 12/31/2020 |
ESSA Pharma Inc.
| EPIX | COM NEW | 4,565,242 | 859,953 | 64,826,436 | 20,622,339 | | |
Hist
| 12/31/2021 |
APPLIED BIOSYSTEMS INC.
| CRA | Common Stock | 8,017,692 | 2,437,530 | 52,756,413 | 19,554,449 | | |
Hist
| 02/09/2010 |
PIERIS PHARMACEUTICALS, INC.
| PIRS | COM | 7,406,643 | 1,805,061 | 27,997,111 | 13,993,156 | | |
Hist
| 12/31/2021 |
CytomX Therapeutics, Inc.
| CTMX | Common | 5,576,471 | 2,387,523 | 36,525,885 | 13,948,133 | | |
Hist
| 12/31/2020 |
Ovid Therapeutics Inc.
| OVID | COM | 6,631,051 | 2,109,000 | 24,269,647 | 13,823,709 | | |
Hist
| 04/13/2021 |
Verastem, Inc.
| VSTM | Common | 17,062,158 | 5,881,164 | 34,977,424 | 11,161,907 | | |
Hist
| 12/31/2021 |
CONCERT PHARMACEUTICALS, INC.
| CNCE | COM | 1,381,845 | 231,400 | 18,309,446 | 3,871,362 | | |
Hist
| 01/28/2019 |
Regulus Therapeutics Inc.
| RGLS | Common | 13,974,249 | 1,025,020 | 14,533,219 | 3,137,897 | | |
Hist
| 12/31/2017 |
CURIS INC
| CRIS | Common Stock | 6,358,091 | 225,000 | 7,693,290 | 3,093,472 | | |
Hist
| 04/27/2009 |
ICAGEN INC
| ICGN | COM | 1,052,000 | 452,000 | 6,312,000 | 2,736,000 | | |
Hist
| 09/06/2011 |
Viracta Therapeutics, Inc.
| SNSS | COM | 11,653,925 | 7,758,899 | 3,935,530 | 2,316,368 | | |
Hist
| 12/31/2019 |
Spero Therapeutics, Inc.
| SPRO | Common | 3,411,520 | 643,242 | 54,618,435 | 941,525 | | |
Hist
| 12/31/2021 |
CONTRAFECT Corp
| CFRX | Common | 3,972,300 | 1,063,387 | 15,690,585 | -162,991 | | |
Hist
| 04/13/2021 |
PALATIN TECHNOLOGIES INC
| PTN | COM NEW | 5,200,000 | 1,708,991 | 2,496,000 | -785,548 | | |
Hist
| 10/05/2011 |
Repare Therapeutics Inc.
| RPTX | Common | 4,858,761 | 1,136,363 | 102,471,269 | -825,275 | | |
Hist
| 12/31/2021 |
GLYCOMIMETICS INC
| GLYC | COM | 9,544,262 | 2,182,461 | 35,886,425 | -3,057,502 | | |
Hist
| 12/31/2020 |
GENOCEA BIOSCIENCES, INC.
| GNCA | COM | 7,614,455 | 114,455 | 2,183,826 | -3,891,174 | | |
Hist
| 12/31/2018 |
Cidara Therapeutics, Inc.
| CDTX | COM | 4,461,494 | 1,092,736 | 8,922,988 | -4,013,043 | | |
Hist
| 12/31/2020 |
X4 Pharmaceuticals, Inc
| XFOR | Common | 3,027,672 | 1,308,056 | 6,933,369 | -4,123,762 | | |
Hist
| 12/31/2021 |
GENOCEA BIOSCIENCES, INC.
| GNCA | Stock | 5,930,353 | 644,804 | 6,879,209 | -5,911,819 | | |
Hist
| 12/31/2021 |
Regulus Therapeutics Inc.
| RGLS | COMMON | 9,661,235 | 2,610,771 | 3,043,289 | -6,474,837 | | |
Hist
| 12/31/2021 |
Calithera Biosciences, Inc.
| CALA | COM | 7,452,331 | 3,091,093 | 14,308,476 | -7,105,203 | | |
Hist
| 07/06/2021 |
Cogent Biosciences, Inc.
| COGT | Common | 3,114,532 | 282 | 26,722,685 | -8,250,343 | | |
Hist
| 12/31/2021 |
Molecular Templates, Inc.
| MTEM | Common | 3,379,599 | 618,478 | 13,248,028 | -12,678,898 | | |
Hist
| 12/31/2021 |
ANAPTYSBIO, INC
| ANAB | Common | 1,441,565 | 847,168 | 21,306,331 | -38,561,335 | | |
Hist
| 01/23/2020 |
|
|
|
|